DOA
BEAT

D'Orazio & Associates’s BioTelemetry, Inc. BEAT Stock Holding History

D'Orazio & Associates’s Portfolio BEAT Stock Details BEAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-500
Closed -$17K – 352
2017
Q2 		$17K Hold
500
– – 0.01% 199
2017
Q1 		$14K Buy
+500
New +$12.4K 0.01% 202

Other funds holding BEAT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

D'Orazio & Associates's BEAT Position: Q3 2017 in Review

D'Orazio & Associates sold out of BioTelemetry, Inc. (BEAT) in Q3 2017, closing a stake of 500 shares — an estimated $17K sold.

D'Orazio & Associates first reported a position in BEAT in Q1 2017 and held it in 2 quarters. The position peaked at $17K in Q2 2017. 211 funds tracked by Wall St. Rank hold BEAT as of Q3 2017.

  • D'Orazio & Associates reported no remaining BioTelemetry, Inc. position as of Q3 2017 after selling out during the quarter.
  • D'Orazio & Associates sold 500 BioTelemetry, Inc. shares in Q3 2017, an estimated $17K.
  • D'Orazio & Associates first reported a position in BioTelemetry, Inc. in Q1 2017 and held it in 2 quarters.
  • D'Orazio & Associates's BioTelemetry, Inc. position peaked at $17K in Q2 2017.
  • 211 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q3 2017.

Based on D'Orazio & Associates's 13F filing for Q3 2017, filed 14 Nov 2017.